PreAxia Health Care Payment Sys
0.2200+0.00 (+0%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · PAXH · USD
Key Stats
Market Cap
9.57MP/E (TTM)
-Basic EPS (TTM)
-0.04Dividend Yield
0%Recent Filings
10-Q
Q1 FY2026 results
PreAxia Health Care Payment Systems posted no revenue for Q1 FY2026 ended August 31, 2025, while operating expenses surged to $875,203 from $4,627 a year earlier, driven by $391,263 in research and development and $387,500 in management costs—mostly from stock subscriptions for services. This yielded an operating loss of $875,203, matching the net loss after minor interest income, with diluted EPS at $(0.04) on 19,767,698 shares; potential dilutive equivalents were excluded due to losses. Cash climbed to $130,285 from zero, fueled by $200,000 in stock subscriptions and $204,858 in net financing inflows, while related-party debt conversions trimmed liabilities to $722,963 from $2.3M. New subsidiaries Zane Inc. CA and US bolster development of health payment and financial management tools. Yet competition in the emerging HSA market poses ongoing challenges.
8-K
PreAxia launches AI finance subsidiaries
PreAxia Health Care Payment Systems entered an Independent Contractor Agreement on July 1, 2025, with Independent Analytical Research Corp. for Pravel Bondarev's services, appointing him CEO of new subsidiaries Zane Inc. CA and Zane Inc. US, focused on AI-powered financial tools for Gen Z including a high-interest super account and smart debit card. Bondarev joined the board on June 30, 2025, amid equity moves like converting $1,525,577 debt to 15,255,770 shares at $0.10 and selling 800,000 shares for $200,000. Subsidiaries target automated money management. Yet risks linger in unproven tech rollout.
10-K
FY2025 results
PreAxia Health Care Payment Systems Inc. reported zero revenue for FY2025 ended May 31, 2025, matching the prior year, with operating expenses climbing 53% to $152,124 from $99,449, driven by higher consulting fees and professional costs tied to audit work. The net loss narrowed to $53,687 from $99,449, aided by a $70,114 gain on settling old payables, while cash dwindled to zero from $14 and working capital deficit eased slightly to $2.3 million. No quarterly breakdowns appear in the filing, but momentum stalled in this development-stage fintech, with no operations from new subsidiary Zane Inc. CA before June 2025. Related-party debt persists at $1.8 million, non-interest bearing. No guidance disclosed. Substantial doubt lingers over going concern amid funding needs.
10-Q
Q3 FY2025 results
PreAxia Health Care Payment Systems posted zero revenue for Q3 FY2025 ended February 28, 2025, matching last year, while operating expenses climbed 53% y/y to $13,463, driven by higher professional fees from the annual audit, yielding a net loss of $13,463—up from $8,810. Over nine months, expenses plunged 67% y/y to $31,756 after skipping CEO consulting fees, trimming the YTD net loss to $31,756 from $94,838, with diluted EPS steady at $(0.00) across 19,767,698 shares. Cash dwindled to $3 from $14, but operations eked out $387 in cash flow, offset by a $398 financing outflow that cleared bank debt. Related-party debt, including a $1,058,760 convertible note, sustains the $2.4M liability stack amid a $2.4M deficit. No non-GAAP metrics disclosed in the 10-Q. Competition in health payment processing looms large.
8-K
Preaxia LOI for Right acquisition
Preaxia Health Care Payment Systems entered a non-binding letter of intent on January 29, 2025, to acquire all shares of U.S.-based Right Inc. via a share exchange, with valuation details pending. The deal merges Preaxia's capabilities with Right's Zane Money.com platform to launch an AI-driven tool integrating budgeting, banking, payments, investments, and HSAs for streamlined personal finance. Closing targets within 90 days, subject to agreed conditions. This positions Preaxia to tap innovative fintech solutions.
BTSG
BrightSpring Health Services, I
34.05+0.05
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.39+0.00
DH
Definitive Healthcare Corp.
2.77-0.17
PAYS
Paysign, Inc.
5.44-0.30
PBSV
Pharma-Bio Serv, Inc.
0.65+0.00
PHLT
Performant Healthcare, Inc.
7.75+0.00
PHR
Phreesia, Inc.
23.22-0.19
PINC
Premier, Inc.
28.11-0.07
PRVA
Privia Health Group, Inc.
25.60-0.33
WAY
Waystar Holding Corp.
39.62+0.13